department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Bavencio · pharmadog

pharmadog
drugs
Bavencio

drug

patient view →

avelumab

Marketedupdated 2mo ago

by EMD Serono Inc

Approved

community read0 votes

all catalysts(1)

phase 1 2 completion · 1

phase 1 2 completion

Bayer AG — avelumab (Phase I/II Trial Completion)

News(0)

no news has mentioned this drug yet

brand

Bavencio

generic

avelumab

indication

Merkel Cell Carcinoma

phase

marketed

Data sources

ClinicalTrials.gov

last refreshed 49m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

🐶 often sniffed alongside

top 4

tagOncology3 co-mentions · 1 sources
tagProstate Cancer3 co-mentions · 1 sources
companyBayer AG1 co-mentions · 1 sources
tagOrthopedics1 co-mentions · 1 sources

Trials studying avelumab

phase2A Study of the Safety and Efficacy of Various Combinations of Avelumab as Therapy in Locally Advanced or Metastatic Urothelial Carcinoma (JAVELIN Bladder Medley)active not recruitingn=256
phase3Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)active not recruitingn=956
phase2Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Canceractive not recruitingn=145
phase2DEPECA-1 - A Phase II Study to Evaluate a First-line Systemic Therapy With Enfortumab Vedotin Plus Avelumab for Advanced and Metastatic Penile Carcinomarecruitingn=25
phase3Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closingactive not recruitingn=68
phase3Adjuvant Avelumab in Merkel Cell Canceractive not recruitingn=101
phase2Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancerrecruitingn=96
phase2TALAVE: Induction Talazoparib Followed by Combination of Talazoparib and Avelumab in Advanced Breast Canceractive not recruitingn=24

more trials →